Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome.
暂无分享,去创建一个
F. Gejyo | M. Arakawa | S. Nishi | S. Suzuki | N. Imai | M. Ueno | R. Karasawa | S. Kawashima | H. Shimada | N. Iino | N. Saito | S. Iguchi | K. Saito | H. In | Y. Oosawa
[1] A. Levin,et al. Management of membranoproliferative glomerulonephritis: evidence-based recommendations. , 1999, Kidney international. Supplement.
[2] T. Wada,et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] S. Yasumura,et al. A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody, frequency of viremia, biochemical abnormality and histological changes. , 1999, Liver.
[4] C. Pomeroy,et al. Renal manifestations of hepatitis C infection. , 1999, The American journal of medicine.
[5] G. Kirsztajn,et al. Prevalence of Hepatitis C Virus Antibodies in Primary Glomerulonephritis in Brazil , 1998, American Journal of Nephrology.
[6] V. Paradis,et al. Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. , 1998, Kidney international.
[7] Mark E. Johnson,et al. Hepatitis C virus and depression in drug users , 1998, American Journal of Gastroenterology.
[8] H. Inoko,et al. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. , 1998, Japanese circulation journal.
[9] John P. Johnson,et al. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] R. Brenard. Practical management of patients treated with alpha interferon. , 1997, Acta gastro-enterologica Belgica.
[11] A. Matsumori. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide. , 1997, Japanese circulation journal.
[12] J. Torras,et al. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. , 1996, Journal of the American Society of Nephrology : JASN.
[13] A. Komatsuda,et al. Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy. , 1996, Internal medicine.
[14] C. Janot,et al. Epidemiology of HCV infection in the general population and in blood transfusion. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] J. Pawlotsky,et al. Type I membranoproliferative glomerulonephritis and HCV infection. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] S. Chopra,et al. Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations , 1995, Annals of Internal Medicine.
[17] R. Pedersen,et al. Long-term prognosis in idiopathic membranoproliferative glomerulonephritis. , 1995, Scandinavian journal of urology and nephrology.
[18] D. Gretch,et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. , 1995, Journal of the American Society of Nephrology : JASN.
[19] P. Ruiz,et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. , 1995, Transplantation.
[20] P. Knoflach,et al. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment. , 1995, The American journal of gastroenterology.
[21] S. Ruddy,et al. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] C. Alpers,et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] D. Gretch,et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-α , 1995 .
[24] A. A. Jones,et al. Hepatitis C associated glomerulonephritis. , 1995, American journal of nephrology.
[25] C. Alpers,et al. Hepatitis C virus-associated glomerulonephritis. Effect of α-interferon therapy , 1994 .
[26] L. Pucillo,et al. Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from viruslike particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. , 1994, Current opinion in nephrology and hypertension.
[27] C. Alpers,et al. Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. , 1994, Kidney international.
[28] R. Rodby,et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. , 1993, Journal of the American Society of Nephrology : JASN.
[29] G. Müller,et al. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. , 1992, Pathology, research and practice.
[30] H J Alter,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.
[31] Jules L. Dienstag,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .